Rapid Test Kit Antigen and Influenza A/B Combo Rapid Test Kit High Accuracy 20 Tests Professional Use Rapid Test Kit

Intended Use
The rapid test kit is intended for qualitative detection and differentiation of nucleocapsid protein antigens from SARS-CoV-2, influenza type A and influenza type B in the same time directly from nasal/nasopharyngeal (NS/NP) swab, oropharyngeal (OP) swab and saliva specimens from patients with signs and symptoms of respiratory viral infection. The test kit is for professional use only.
Specification

Performance Characteristics

Main Components

• 20 Test cassettes
• 2 Sample extraction buffers
• 20 Sample tubes
• 20 Swabs
• 1 Tube Stand
• 1 Package Insert

Sample Collection

• By nasopharyngeal swab: The sampler gently holds the head of the person to be collected with one hand, holds the swab with the other hand, sticks the swab to the nostril to enter, and slowly penetrates backwards along the bottom of the lower nasal passage, so as not to exert too much force to avoid traumatic hemorrhage. When the tip of the swab reaches the posterior wall of the nasopharynx cavity, gently rotate it for one week (in case of reflex cough, stop for a minute), and then slowly take out the swab.
• By oropharyngeal swab: The head of the person to be collected is slightly tilted and his mouth is wide open, exposing the pharyngeal tonsils on both sides. Wipe the swab across the root of the tongue. Wipe the pharyngeal tonsils on both sides of the person to be collected back and forth with a little force for at least 3 times, and then wipe up and down the posterior pharyngeal wall for at least 3 times.

Use Step

• Take out the test cassette from the sealed pouch, place it on a clean and level surface with the sample port well up.

• Apply 2 full drops of the treated sample (60μl-70μl) vertically into each of the two sample wells of the test cassette.

• Observe the test results immediately within 15~20 minutes, the result is invalid over 20 minutes.

Interpretation Of Result

• POSITIVE: The presence of T (T on nCoV /A or B on Flu) and C lines within the reaction window indicate a positive result on SARS-CoV-2 or Flu A and/or B infection or co-infection.

• NEGATIVE: One colored line appears in the control region(C). No apparent colored line appears in the test region (T on nCoV /A or B on Flu). The negative result does not indicate the absence of analytes in the sample, it only indicates the level of tested analytes in the sample is less than the minimum detection limit

• INVALID: No colored lines appear, or control line fails to appear, indicating that the operator error or reagent failure. Verify the test procedure and repeat the test with a new testing device.

Feature

• Simple, One-step Operation easy for use
• Fast, Excellent performance get the result in 15 mins
• Best quality, After test the background is clean and result is easy to read
• High Accuracy, Sensitivity and Specificity up to 90%.

FAQ

• MOQ

We have the MOQ limit, which is 10000 pices.

• Delivery date

About 1 week include export application, commodity inspection, customs clearance and air flight, all are necessary processes for China test kits.

• Register the products in my country

Sure, we will provide all you documents and samples you need for register.

• Lead time

Usually 1-7 days, since it was produced against specific demands to guarantee most freshness.

• Shipment

We choose Air cargo or Ocean cargo and International EXPRESS(DHL).

Labnovation Technologies, Inc. is an original manufacturer established in Shenzhen, China since 2001. We are dedicated in developing and manufacturing IVD instruments and reagents including HbA1c analyzer and reagents, rapid test reader & reagents, hematology reagents, clinical chemistry reagents, electrolyte reagents, wash solution and urine test reagents.
 

Labnovation products are developed in house, tested extensively in clinics and passed strict quality controls. All of our products are CE marked and approved by SFDA. In the past 15 years, our products have been exported to 110 different countries and used in 8000 hospitals worldwide. We provide both ready-to-use final products and bulk OEM reagents, including ready-to-use reagents, concentrated, and powder.

With an investment of 10% of our annual sales into R&D, we release new products every years. We win more and more domestic and international cooperation by company reputation and products quality while we actively take part in fairs like MEDICA,AACC, ARBA HEALTH and so on through which we are well-known by the companies in this field.